TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive Hagop Kantarjian: Why Drugs Cost Too Much and How Prices Can be Brought Down May 31, 2013
TCL Archive University of Wisconsin wins $7 million NIH construction grant for cancer center. June 25, 2004
